Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumacaftor/Ivacaftor in CF Homozygous for F508del
NCT01807923Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- May 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of lumacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started May 2013; status: completed.
02
Drugs
lumacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01807923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807923.